Photocycle associated with Cyanobacteriochrome TePixJ: Revision history

Jump to: navigation, search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 January 2024

3 January 2024

  • curprev 09:4009:40, 3 January 2024‎ Johnshadow70 talk contribs‎ 3,443 bytes +3,443‎ Created page with "Suitable patients obtained 2 to three preceding wide spread remedies. Patients obtained nivolumab 240 plus milligram Q2W for≤24 a few months or until finally established further advancement or perhaps improper toxicity. The main endpoint ended up being occurrence involving high-grade (rank 3-5) immune-mediated unfavorable occasions (IMAEs). Exploratory endpoints integrated objective result charge (ORR), progression-free tactical (PFS), and total emergency (Operating sy..."
Retrieved from "https://news.npo.digital/index.php?title=Photocycle_associated_with_Cyanobacteriochrome_TePixJ"